156 filings
Page 3 of 8
S-8
2e4tp
30 Jun 22
Registration of securities for employees
4:05pm
8-K
zzl6d
24 Jun 22
Entry into a Material Definitive Agreement
5:23pm
DEFR14A
z5p38fo
12 May 22
Revised proxy
5:00pm
8-K
vea2cr8 e9c
9 May 22
Arcturus Therapeutics Announces First Quarter 2022 Financial Update and Pipeline Progress
4:20pm
8-K
r28b66h42qpatgcsq9e
20 Apr 22
Arcturus Announces Self-amplifying COVID-19 mRNA Vaccine Candidate ARCT-154 Meets Primary Efficacy Endpoint in Phase 3 Study
5:24pm
8-K
knk8r5hy
28 Feb 22
Arcturus Therapeutics Announces Fourth Quarter and Full Year 2021 Financial Update and Pipeline Progress
4:15pm
8-K
suyvobx
17 Feb 22
Other Events
7:57am
8-K
29zuka
11 Feb 22
Departure of Directors or Certain Officers
5:00pm
8-K
1e976ptt3now
11 Jan 22
Regulation FD Disclosure
7:00am
8-K
xvkqjeyogk237cnsnc
13 Dec 21
Arcturus Therapeutics Appoints Jing Marantz, M.D., Ph.D., M.B.A. to its Board of Directors
5:17pm
8-K
dqpbcooqh jntveao7
16 Nov 21
Other Events
4:15pm
8-K
9bufxbh
8 Nov 21
Arcturus Therapeutics Announces Third Quarter 2021 Financial Update and Pipeline Progress
4:18pm
8-K
jr4rxvgubedv4q
1 Nov 21
Entry into a Material Definitive Agreement
4:30pm
S-8
0ap 505pfmp9cvxd2y6q
20 Oct 21
Registration of securities for employees
5:23pm
8-K
fesi8m iwg51
5 Oct 21
Entry into a Material Definitive Agreement
5:01pm